A Multi-Center Study of MYOBLOC for the Treatment of Sialorrhea in Parkinson's Disease Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

September 30, 2008

Conditions
Drooling
Interventions
BIOLOGICAL

Botulinum Toxin Type B (Myobloc)

BIOLOGICAL

Matched placebo to Myobloc

Trial Locations (18)

12205

Dr. Eric Molho, Albany

20007

Dr. Fernando Pagan, Washington D.C.

21201

Dr. Stephen Reich, Baltimore

29401

Dr. Vanessa Hinson, Charleston

30329

Dr. Alan Freeman, Atlanta

32610

Dr Hubert Fernandez, Gainesville

37923

Dr. Sam Kabbani, Knoxville

52242

Dr. Robert Rodnitzky, Iowa City

60612

Dr. Katie Kompoliti, Chicago

63110

Dr. Brad Racette, St Louis

75231

Dr. Madhavi Thomas, Dallas

80262

Dr. Olga Klepitskaya, Denver

84132

Dr. Gordon Smith, Salt Lake City

85259

Dr Virgilio Evidente, Scottsdale

91325

Dr. Ronald Ziman, Northridge

93030

Dr. James Sutton, Oxnard

98405

Dr. Patrick Hogan, Tacoma

02886

Dr. Joseph Friedman, Warwick

Sponsors
All Listed Sponsors
lead

Solstice Neurosciences

INDUSTRY